---
layout: splash
title: 에이비엘바이오 (298380)
excerpt: 에이비엘바이오의 최근 공시, 수익률, 주요 재무/기술 지표
header:
  overlay_color: "#333"
  show_overlay_excerpt: false
categories:
- KOSDAQ
- Q:제약
- 고PER
- 고PBR
keywords: 에이비엘바이오, 298380
---

| **종가** | **전일대비** | **업종** | **PER** | **PBR** | **DIV** |
| -------: | -----------: | -------: | ------: | ------: | ------: |
| 27,150 | <span style="color: cornflowerblue">-2.7<small>%</small></span> | Q:제약 | 405.2 | 18.7 | - |

<!-- more -->


> **기업 개요**<a id="company"></a>

| <span style="white-space:nowrap;">**섹터**</span> | Q:제약 / 기초 의약물질 및 생물학적 제제 제조업 |
| <span style="white-space:nowrap;">**산업**</span> | 항체의약품 연구개발 |
| <span style="white-space:nowrap;">**상장**</span> | KOSDAQ / 2018년 12월 19일 상장 / 12월 결산 |
| <span style="white-space:nowrap;">**대표자**</span> | 이상훈 |
| <span style="white-space:nowrap;">**홈페이지**</span> | [http://www.ablbio.com](http://www.ablbio.com){:target="_blank"} |


> **최근 7일 DART 신규 공시**<a id="dart"></a>

| **일자** |      | **보고서명** |
| :------- | :--- | :----------- |
| 03&#x2011;14 | | [[기재정정]사업보고서 (2023.12)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240314001689){:target="_blank"} |
|  | | [의결권대리행사권유참고서류](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240314001251){:target="_blank"} |
|  | | [주주총회소집공고](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240314001238){:target="_blank"} |
|  | | [주주총회집중일개최사유신고              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240314900591){:target="_blank"} |
|  | | [주주총회소집결의              (정기주주총회)](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240314900550){:target="_blank"} |
| 03&#x2011;13 | | [감사보고서제출              ](https://dart.fss.or.kr/dsaf001/main.do?rcpNo=20240313902799){:target="_blank"} |


> **주가 흐름**<a id="price"></a>

![298380](/stock/images/298380.png){: .align-center}


> **주요 가격 변동 지표**<small>[^fn_price_metric]</small>

| **종가** | **전일대비** | **5일** | **20일** | **60일** | **120일** |
| -------: | -----------: | ------: | -------: | -------: | --------: |
| 27,150 | <span style="color: cornflowerblue">-2.7<small>%</small></span> | <span style="color: tomato">3.2<small>%</small></span> | <span style="color: tomato">32.8<small>%</small></span> | <span style="color: tomato">33.7<small>%</small></span> | <span style="color: tomato">33.1<small>%</small></span> |
| **1년** | **편차** | **샤프** | **MDD** | **AvDD** | **MARr** |
| <span style="color: tomato">31.4<small>%</small></span> | 47.0<small>%</small> | 0.67 | -39.3<small>%</small> | -18.3<small>%</small> | -0.8 |


> **주요 재무 지표**<small>[^fn_finance_metric]</small>

| **업종**<small>[^fn_sector_abbr]</small> | **PER** | **PBR** | **DIV** | **평가**<small>[^fn_finance_basic_tags]</small> |
| :--------------------------------------- | ------: | ------: | ------: | ----------------------------------------------: |
| Q:제약 | 405.2 | 18.7 | - | 고PER, 고PBR |



{% include /commons/ads/adsense.html %}

> **세부 재무/투자 정보 제공 사이트**

| [네이버](https://m.stock.naver.com/domestic/stock/298380/finance/summary){:target="_blank"}<sup><small>모바일</small></sup> | [네이버](https://finance.naver.com/item/coinfo.naver?code=298380){:target="_blank"} | [FnGuide](https://comp.fnguide.com/SVO2/ASP/SVD_Invest.asp?gicode=A298380&MenuYn=Y){:target="_blank"} |
| :---: | :---: | :---: |
| [와이즈리포트](https://comp.wisereport.co.kr/company/c1040001.aspx?cmp_cd=298380){:target="_blank"} | [밸류라인](https://www.valueline.co.kr/finance/summary/298380){:target="_blank"} | [한국경제](https://markets.hankyung.com/stock/298380/financial-summary){:target="_blank"} |


> **주요 기술 지표**<small>[^fn_tech_metric]</small>


![298380](/stock/images/298380_tech.png){: .align-center}

| **기술 지표** | **1년** | **편차** | **샤프** | **MDD** | **AvDD** |
| :------------ | ------: | -----------: | -------: | ------: | -------: |
| 거치식 | 31.4<small>%</small> | 47.0<small>%</small> | 0.67 | -39.3<small>%</small> | -18.3<small>%</small> |
| 적립식[^fn_tech_metric_dca] | 32.2<small>%</small> | 45.9<small>%</small> | 0.70 | -33.6<small>%</small> | -15.4<small>%</small> |
| Sig. M[^fn_tech_metric_sigm] | 25.8<small>%</small> | 37.8<small>%</small> | 0.68 | -44.1<small>%</small> | -21.8<small>%</small> |
| SMA<small><sub>(5)</sub></small>[^fn_tech_metric_sma_i] | 51.0<small>%</small> | 36.0<small>%</small> | 1.42 | -24.8<small>%</small> | -9.6<small>%</small> |
| SMA<small><sub>(20)</sub></small>[^fn_tech_metric_sma_i] | 6.4<small>%</small> | 33.4<small>%</small> | 0.19 | -26.8<small>%</small> | -16.0<small>%</small> |
| SMA<small><sub>(60)</sub></small>[^fn_tech_metric_sma_i] | 10.4<small>%</small> | 35.3<small>%</small> | 0.30 | -25.1<small>%</small> | -14.1<small>%</small> |
| SMA<small><sub>(120)</sub></small>[^fn_tech_metric_sma_i] | 8.4<small>%</small> | 32.2<small>%</small> | 0.26 | -24.6<small>%</small> | -17.6<small>%</small> |
| SMA<small><sub>(240)</sub></small>[^fn_tech_metric_sma_i] | 7.1<small>%</small> | 30.6<small>%</small> | 0.23 | -23.3<small>%</small> | -15.1<small>%</small> |
| MACD[^fn_tech_metric_macd] | 25.5<small>%</small> | 34.2<small>%</small> | 0.75 | -22.2<small>%</small> | -12.8<small>%</small> |


> **주가 흐름 유사 종목**<a id="corr"></a><small>[^fn_corr_long]</small>

![298380](/stock/images/298380_corr.png){: .align-center}

|       | [지씨셀](/144510/) | [녹십자홀딩스](/005250/) | [HLB](/028300/) |
| :---: | :------------------------------------: | :------------------------------------: | :------------------------------------: |
|       | [HLB생명과학](/067630/) | [넷마블](/251270/) | [한미사이언스](/008930/) |


> **가상 레버리지 상품에 투자했다면**<a id="2x"></a><small>[^fn_lev]</small>

![298380](/stock/images/298380_2x.png){: .align-center}


> **관련 정보**

- [Q:제약 업종 목록](/stats/sector/kosdaq_업종_제약_종목/){: .btn .btn--info} [고PER 목록](/fn/fn_high_per/){: .btn .btn--info} [고PBR 목록](/fn/fn_high_pbr/){: .btn .btn--info}

{% include commons/footnotes.md %}